Table 2.

Reasons leading to DTG/3TC discontinuation

Reason	Number
Death Neoplastic disease End-stage liver disease Myocardial infarction Sepsis Unknown case	11 6 2 1 1 1
Adverse events Weight gain Insomnia/neurological symptoms Mialgia Other	13 3 5 3 2
Drug unrelated causes Lost to follow-up Patient’s decision Moved to other center Anti-neoplastic therapy	20 10 6 3 1
Back to triple drug regimen Poor adherence Not reported	4 2 2